Per ulteriori informazioni selezionare i riferimenti di interesse.
A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2
CLINICAL CANCER RESEARCH
Enhancement of tumor oxygenation and radiation response by the allosteric effector of hemoglobin, RSR13
Preclinical evaluation of the orally active camptothecin analog, RFS-2000 (9-nitro-20(S)-camptothecin) as a radiation enhancer
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Combined effects of the orally active cisplatin analog, JM216, and radiation in antitumor therapy
CANCER CHEMOTHERAPY AND PHARMACOLOGY